J&J COVID-19 vaccine in limbo as U.S. panel delays vote on resuming shots
(Reuters) -Johnson & Johnson’s COVID-19 vaccine remained in limbo on Wednesday as a U.S. health panel called for more data …
Home »
(Reuters) -Johnson & Johnson’s COVID-19 vaccine remained in limbo on Wednesday as a U.S. health panel called for more data …
(Reuters) – A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the …